Nurix Therapeutics, Inc.
NRIXHealthcareBiotechnology
市值
$2.08B
CEO
Arthur T. Sands
员工数
314
行业
Biotechnology
上市日期
2020-07-24
收录人数
13
近期高管变动
11/10上任Roger Dansey, M.D. Director of the Company and Member of the Clinical and Commercialization Committee of the Board08/22resignedLori A. Kunkel, M.D. Class III director of the Board, chair of the Clinical and Commercialization Committee, member of the Clinical and Commercialization Committee and the Compensation Committee of the Board08/22上任Roy D. Baynes, MB.Bch., M.Med., Ph.D. chair of the Clinical and Commercialization Committee of the Board03/13上任Roy D. Baynes, MB.Bch., M.Med., Ph.D. director of the Company and member of the Clinical and Commercialization Committee of the Board10/16上任Anil Kapur director of the Company and member of the Development Advisory Committee of the Board04/10resignedStefani A. Wolff Chief Operating Officer and Executive Vice President of Product Development09/14上任Edward C. Saltzman Director of the Company, Member of the Compensation Committee of the Board, Member of the Development Advisory Committee of the Board
A
Arthur Sands
President, CEO
董事高管
R
Roy Baynes5家
董事
董事
A
Anil Kapur4家
董事
董事
L
Lori Kunkel4家
董事
董事
J
Judith Reinsdorf3家
董事
董事
R
Roger Dansey3家
董事
董事
D
David Lacey2家
董事
董事
J
Julia Gregory2家
董事
董事
P
Paul Silva2家
董事
董事
E
Edward Saltzman
董事
董事